The N-methyl-D-aspartate (NMDA) subtype of ionotropic glutamate receptors (iGluRs) is a tetrameric protein composed of homologous NR1 and NR2 subunits, which require the binding of glycine and glutamate, respectively, for efficient channel gating. The extracellular N-terminal domains (NTDs) of iGluR subunits show sequence homology to the bacterial periplasmic leucine/isoleucine/valine binding protein (LIVBP) and have been implicated in iGluR assembly, trafficking, and function. Here, we investigated how deletion of the NR1-and NR2-NTDs affects the expression and function of NMDA receptors. Both proteolytic cleavage of the NR1-NTD from assembled NR1/ NR2 receptors and coexpression of the NTD-deleted NR1 subunit with wild-type or NTD-deleted NR2 subunits resulted in agonist-gated channels that closely resembled wild-type receptors. This indicates that the NTDs of both NMDA receptor subunits are not essential for receptor assembly and function. However, deletion of either the NR1 or the NR2 NTD eliminated high-affinity, allosteric inhibition of agonist-induced currents by Zn 2ϩ and ifenprodil, consistent with the idea that interdomain interactions between these domains are important for allosteric receptor modulation. Furthermore, by replacing the NR2A-NTD with the NR2B NTD, and vice versa, the different glycine affinities of NR1/NR2A and NR1/NR2B receptors were found to be determined by their respective NR2-NTDs. Together, these data show that the NTDs of both the NR1 and NR2 subunits determine allosteric inhibition and glycine potency but are not required for NMDA receptor assembly.
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Excitatory neurotransmission in the mammalian brain is mainly mediated by ionotropic glutamate receptors (iGluRs).
Based on pharmacological studies, iGluRs have been grouped into three distinct subfamilies: AMPA receptors (GluR1-4), kainate receptors (GluR5-7, KA1, 2), and NMDA receptors (NR1, NR2A-D, NR3A, B) (overview in Dingledine et al., 1999; Cull-Candy et al., 2001 ). All iGluR subunits share a common modular design characterized by 1) an extracellular N-terminal domain (NTD) of approximately 400 amino acids that shows sequence homology to the bacterial periplasmic leucine/isoleucine/valine binding protein (LIVBP) and has been implicated in iGluR subunit oligomerization, trafficking, and function; 2) a S1S2 ligand binding domain (LBD) composed of an extracellular region preceding the first transmembrane domain and a second extracellular region connecting the transmembrane segments 2 and 3; 3) a membrane re-entrant loop domain located between transmembrane segments 1 and 2, which lines the ion channel; and 4) an intracellular carboxyterminal tail region that interacts with postsynaptic scaffolding and signal transduction proteins (reviewed in Madden, 2002) .
Among iGluRs, NMDA receptors stand out with respect to both their molecular diversity and their particular pharmacological and functional properties (Dingledine et al., 1999) . Within the heterotetrameric receptor proteins, various splice variants of the glycine-binding NR1 subunit (Kuryatov et al., 1994) coassemble with glutamate-binding NR2 (Laube et al., 1997) and/or glycine-binding NR3 subunits (Yao and Mayer, 2006) . Activation of NMDA receptors is a complex process that requires ambient glycine and release of glutamate from presynaptic terminals in coincidence with postsynaptic membrane depolarization, which relieves the receptor channel from a voltage-dependent block by Mg 2ϩ ions. NMDA receptor function is regulated by allosteric inhibitors, such as Zn 2ϩ and the phenylethanolamine ifenprodil, which bind to the NTDs of NR2A and NR2B subunits (Herin and Aizenman, 2004) and enhance receptor desensitization (Krupp et al., 1998; Zheng et al., 2001 ). The molecular basis of allosteric NMDA receptor inhibition is poorly understood but has been attributed to interactions between the NTD and the LBD of the NR2 subunits (Paoletti et al., 2000) . Deletion of the NR2A and NR2B NTDs generates NMDA receptors that display a reduced inhibition by both Zn 2ϩ and ifenprodil (Paoletti et al., 2000) . The role of the NR1-NTD has not been investigated further, because N-terminal truncations within the NR1 subunits have been reported to impair receptor function upon coexpression with NR2 subunits (Meddows et al., 2001) .
Here, we analyzed the role of the NTD of the NR1 subunit in NMDA receptor assembly and allosteric inhibition by both enzymatically cleaving this domain from properly assembled receptors and coexpressing a truncated NR1 subunit with wild-type or NTD-deleted NR2A and NR2B subunits. We find that, like the NR2-NTDs, the NR1-NTD is not required for receptor function and assembly but notably contributes to allosteric Zn 2ϩ and ifenprodil inhibition. In addition, highaffinity glycine binding requires the NTDs of both NR1 and NR2B subunits. Our data suggest that direct interactions between the NR1 and NR2 NTDs determine the potency of allosteric inhibitors and the coagonist glycine.
Materials and Methods
MK801, D-(Ϫ)-2-amino-5-phosphonopentanoic acid, and MDL-29951 were purchased from Tocris (Biotrend, Cologne, Germany). All other chemicals used were obtained from Sigma (Taufkirchen, Germany).
DNA Constructs, Oocyte Expression, and Electrophysiology. cDNAs of the NR1a, NR2A, and NR2B subunits were subcloned into the pNKS2 vector. Mutations were introduced by site-directed mutagenesis (QuikChange XL site-directed mutagenesis kit; Stratagene, Amsterdam, The Netherlands) and confirmed by DNA sequencing. The NR1 ⌬NTD construct was generated by excising the nucleotide sequence encoding amino acids 5 to 358 of the mature protein with the use of PvuI. To enzymatically remove the NTD of NR1, a thrombin recognition sequence (LVPRGS) (Madry et al., 2007) was inserted at position 358 of the NR1 subunit that had been fused to enhanced green fluorescent protein (EGFP-NR1 TCS ) by subcloning into the pEGFP-C1 vector (Clontech, Mountain View, CA). The NR2A
⌬NTD

, NR2B
⌬NTD , NR2A NTD2B , and NR2B NTD2A constructs (Paoletti et al., 2000; Rachline et al., 2005) were kindly provided by Dr. P. Paoletti (Ecole Normale Supérieure, Paris, France). The NR2A*-His construct was generated by replacing the C-terminal region from amino acid 930 with a 6ϫ His tag (Madry et al., 2007) . In vitro synthesis of cRNA (mCAP mRNA Capping Kit; Ambion, Austin, TX) was performed as described previously (Madry et al., 2007) . For heterologous expression of NMDA receptors, 25 ng of cRNA was injected at a NR1:NR2 ratio of 1:2 into Xenopus laevis oocytes. Oocytes were isolated and maintained as described previously (Laube et al., 1997) . Two-electrode voltage-clamp recording of wholecell currents was performed according to Laube et al. (1995) . To monitor the voltage dependence of NR1/NR2B NTD-deleted receptor combinations, 2-s Ϫ80/ϩ40 mV voltage ramps were used. Leakage currents were recorded before agonist/Zn 2ϩ application and subtracted from the agonist/Zn 2ϩ -induced currents. To measure desensitization of receptor responses, we recorded currents upon application of saturating concentrations of glycine and glutamate (100 M, each) until a steady-state plateau was reached. Based on steadystate (I ss ) and peak (I p ) current amplitudes recorded in the same solution, we calculated the extend of desensitization as the percentage (%) of current decay in the continuous presence of the agonists. For thrombin treatment, oocytes were incubated with 30 U/ml protease for 60 min at room temperature. Same oocytes were measured before and after thrombin exposure.
Transfection of HEK293 Cells and Thrombin Treatment. Culture conditions for human embryonic kidney (HEK) 293 cells (American Type Culture Collection, Manassas, VA) have been described previously (Laube et al., 1995) . Transfection with Lipofectamine 2000 was performed according to the manufacturer's protocol (Invitrogen, Carlsbad, CA). HEK293 cells were cotransfected with either EGFP-NR1 (wt) or EGFP-NR1 TCS plasmid together with the NR2A construct, using 20 g of total DNA at a NR1/NR2 ratio of 1:3. Transfected cells were cultured in the presence of the NMDA inhibitors MK801, D-(Ϫ)-2-amino-5-phosphonopentanoic acid, and MDL-29951 (all 100 M) for 48 h. Then new medium without Ca 2ϩ and bovine serum albumin was added, and the cells were incubated with 30 U/ml thrombin for 30 min at 37°C followed by harvesting and homogenization in a Polytron homogenizer (Kinematica, Basel, Switzerland) . After centrifugation at 1000g, the supernatant was centrifuged at 10,000g for 20 min at 4°C to obtain the membrane pellet, which then was suspended in SDS sample buffer.
Metabolic Labeling, Purification, and SDS-PAGE of NMDA Receptor Complexes. Injected oocytes were metabolically labeled by overnight incubation with [
35 S]methionine as described previously (Madry et al., 2007) . After an additional 24-h chase interval, labeled receptor complexes were purified by nickel-nitrilotriacetic acid chromatography from 0.5% (w/v) dodecylmaltoside extracts of the labeled oocytes as detailed previously (Sadtler et al., 2003) . For SDS-PAGE, protein samples were solubilized in SDS sample buffer containing 20 mM dithiothreitol and electrophoresed in parallel with molecular mass markers (Precision Plus Protein All Blue Standard; Bio-Rad Laboratories, Munich, Germany) on 10% Tricine/SDS-polyacrylamide gels. Radioactive gels were dried and exposed to BioMax MR films (Kodak, Stuttgart, Germany) at 80°C or to a phosphorimaging plate for quantification purposes. Phosphor plates were scanned on a Typhoon Trio fluorescence scanner and analyzed with Image Quant TL software (GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK).
Antibodies. Anti-NR1 (generated against amino acids 660-811 of the rat NR1 subunit) and anti-EGFP primary antibodies were purchased from BD Biosciences (Heidelberg, Germany) and used at dilutions of 1:500 (NR1) and 1:1000 (EGFP), respectively. Goat antimouse horseradish peroxidase-linked secondary antibody (Dianova, Hamburg, Germany) was employed at a final dilution of 1:10,000, and immunoreactive bands were detected with the ECL Western blotting system (GE Healthcare, Munich, Germany).
Statistical Analyses. Values given represent means Ϯ S.E. Statistical significance was determined at the p Ͻ 0.01 ‫)ء(‬ and p Ͻ 0.001 ‫)ءء(‬ levels using a Student's two-tailed, unpaired t test.
Results
To investigate the role of the NTD of the glycine-binding NR1 subunit in NMDA receptor assembly and function, we designed two different NR1 cDNA constructs. First, by inserting a thrombin cleavage site (TCS) sequence at amino acid position 358 of the NR1 subunit (EGFP-NR1 TCS ; Fig.  1A ), we generated a NR1 subunit, which should allow proteolytic cleavage of the NR1-NTD from surface-located receptors upon thrombin treatment. Visualization and immunological detection of the respective NR1-NTD fragment was achieved by an N-terminal EGFP tag (see Fig. 1A , and Materials and Methods). Second, a truncated NR1 subunit (NR1 ⌬NTD ; Fig. 1A ) was generated by deleting the nucleotide sequence encoding residues 5 to 358. (Fig. 1B, lanes 1 and 2) . Upon thrombin treatment of the intact cells, membranes prepared from wt EGFP-NR1 and NR2A transfected cells again contained a 130-kDa NR1 protein band that was recognized by both anti-NR1 and anti-EGFP antibodies (Fig. 1B, lanes 3 and 4) . In contrast, treatment of EGFP-NR1 TCS and NR2A subunit-expressing cells with thrombin generated, in addition to the 130-kDa band, two prominent fragments of approximately 60 and 70 kDa that were stained by anti-NR1 and anti-EGFP, respectively (Fig. 1B , lanes 5 and 6). These fragment sizes are consistent with the calculated masses of the membrane-bound "core" NR1 subunit and the truncated EGFP-tagged NTD of the EGFP-NR1 TCS subunit (Fig. 1A ). This indicates an efficient cleavage of surface-located EGFP-NR1 TCS /NR2A receptors, whereas the noncleaved NR1 TCS 130-kDa protein most likely corresponds to thrombin-inaccessible intracellularly located subunits. Furthermore, copurification of the truncated EGFP-tagged NTD in the membrane fraction shows that cleavage of the NR1-NTD by thrombin does not necessarily result in a separation of this domain from the "core" receptor, implying strong noncovalent interactions with the remaining protein.
The consequences of thrombin-mediated cleavage of the NR1-NTD on apparent agonist affinities and maximal inducible currents (I max ) were analyzed by two-electrode voltage clamping after coexpression of EGFP-NR1
TCS with the NR2B subunit in Xenopus laevis oocytes. The resulting glycine and glutamate dose-response curves were indistinguishable to those of the wt NR1/NR2B receptor in the absence and presence of thrombin. In contrast, after thrombin treatment, the EC 50 value of the EGFP-NR1 TCS /NR2B receptor showed a significant decrease in apparent glycine affinity (0.30 Ϯ 0.04 versus 0.80 Ϯ 0.14 M; p Ͻ 0.01, n ϭ 4), whereas the glutamate EC 50 value (1.2 Ϯ 0.4 versus 1.3 Ϯ 0.3 M) and the maximal inducible currents were not significantly changed ( Fig. 2A, left) . Because a similar result was also obtained for EGFP-NR1 TCS /NR2A receptors ( Fig. 2B , left), we conclude that thrombin-mediated cleavage of the NR1 NTD does not impair receptor function.
Cleavage of the NR1-NTD Eliminated High-Affinity Zn 2؉ Inhibition of NR1/NR2 Receptors. Because the NTDs of the NR2 subunits have been found to mediate the allosteric inhibition of NMDA receptors (overview in Herin and Aizenman, 2004) , we also examined the effect of thrombin-mediated NR1-NTD deletion on Zn 2ϩ inhibition of both EGFP-NR1 TCS /NR2B and EGFP-NR1 TCS /NR2A receptor currents. NR2B-containing NMDA receptors are inhibited by micromolar concentrations of Zn 2ϩ (Rachline et al., 2005) . Upon thrombin treatment of oocytes expressing the EGFP-NR1 TCS /NR2B combination, the IC 50 value of Zn 2ϩ increased 19-fold, from 13 Ϯ 3 M before to 256 Ϯ 34 M after incubation with the protease (p Ͻ 0.01, n ϭ 3; Fig. 2A , right). This suggested that the NTD of the NR1 subunit is not essential for receptor function but contributes to allosteric Zn 2ϩ inhibition. To examine whether the NR1-NTD is also required for the biphasic mode of Zn 2ϩ inhibition seen with NR1/NR2A receptors (Williams, 1996; Paoletti et al., 1997) , we determined the effects of Zn 2ϩ on agonist-induced currents of EGFP-NR1 TCS /NR2A-expressing oocytes before and after thrombin treatment (Fig. 2B ). Recordings from untreated oocytes disclosed the typical biphasic Zn 2ϩ inhibition curve with IC 50 values of 0.028 Ϯ 0.005 and 75 Ϯ 8 M for the high-and low-affinity Zn 2ϩ -binding sites, respectively (n ϭ 5). After a 1-h incubation with thrombin, the high-affinity component of In conclusion, thrombin efficiently cleaves surface-localized EGFP-NR1 TCS subunits and thereby strongly reduces the affinity of Zn 2ϩ inhibition at both NR1/NR2A and NR1/NR2B receptors.
N-Terminally Truncated NR1 Subunits Assembled Efficiently into Functional NMDA Receptors. To investigate the importance of the NR1-NTD for receptor assembly, we examined whether an N-terminally truncated NR1 subunit that lacks amino acids 5 to 358 of the mature NR1 subunit (NR1 ⌬NTD , Fig. 1A ) forms heteromeric NMDA receptors after heterologous expression in X. laevis oocytes. To this end, we coexpressed the wt and the NR1 ⌬NTD construct with the tagged NR2A*-His subunit (Madry et al., 2007) in oocytes that were metabolically labeled with [
35 S]methionine. The NR2A*-His subunit was then purified under nondenaturating conditions by metal affinity chromatography from digitonin extracts of the oocytes and analyzed by reducing SDS-PAGE and autoradiography (Sadtler et al., 2003) . Figure 3A , lane 1, shows that two 35 S-labeled bands with apparent molecular masses of approximately 116 and 105 kDa corresponding to those of the NR1 and NR2A*-His subunits, respectively, were coisolated by this protocol. Likewise, coexpression of the NR1
⌬NTD with the NR2A*-His construct resulted in coisolation of two 35 S-labeled bands with molecular masses of approximately 78 and 105 kDa, showing that the NR1
⌬NTD subunit also assembles with NR2A*-His (Fig.  3A, lane 2) . Quantification of the subunit bands by PhosphorImaging revealed a ratio of 35 S-radioactivities of the wt NR1 subunit to the NR2A*-His polypeptide of 1.09 Ϯ 0.16 (n ϭ 3). This value is in good agreement with the theoretical ratio of 0.93, calculated from the determined subunit stoichiometry of 2NR1:2NR2 (Laube et al., 1998) and the known numbers of 28 and 30 methionine residues per mature NR1 and NR2A*-His subunit, respectively. Analysis of NR1 ⌬NTD /NR2A*-His receptors yielded a ratio of 0.60 Ϯ 0.09 (n ϭ 3) of NR1
⌬NTD to NR2A* subunit radioactivities. This is consistent with a lower number (18) of methionine residues in NR1 ⌬NTD , which predicts a theoretical ratio of 0.60 for a receptor complex containing two NR1 ⌬NTD and two NR2A*-His subunits. Because the intensities of the NR2A*-His polypeptide bands were not different in the affinity-purified NR1/NR2A*-His and NR1
⌬NTD /NR2A*-His receptors, the values obtained for both preparations, at the close-to-theoretical NR1/NR2A ratio of 1:1, indicate that 1) both the wt NR1 and NR1 ⌬NTD subunits assemble at a 2:2 stoichiometry with NR2A*-His, and 2) both NR1 polypeptides show comparable assembly efficiencies. In conclusion, NMDA receptor formation seems not to depend on the NTD of the NR1 subunit.
NTD-Deleted NR1 and NR2 Subunits Generated Functional NMDA Receptors. A previous study has shown that coexpression of NTD-deleted NR2A and NR2B subunits with wt NR1 generates functional NMDA receptors (Paoletti et al., 2000) . To analyze whether the NTD deleted NR1 subunit NR1
⌬NTD assembles into functional receptors upon coexpression with the NR2A or NR2B subunit, we applied saturating glutamate and glycine concentrations (100 M each) to recombinant NR1/NR2B, NR1
⌬NTD /NR2B, NR1/ NR2B ⌬NTD , and NR1 ⌬NTD /NR2B ⌬NTD receptors. All subunit combinations mentioned above were found to produce robust currents with I max values that were not significantly different from each other ( Fig. 3B ; Tables 1 and 2) . Likewise, receptors composed of NTD-deleted NR1 and NR2A subunits displayed robust agonist responses in the presence of saturating agonist concentrations, with I max values similar to those of wt NR1/NR2A receptors (Table  1) . Furthermore, we determined the extent of current decay of NR1/NR2A-, NR1NR2B-, NR1
⌬NTD /NR2A ⌬NTD -, and NR1
⌬NTD /NR2B ⌬NTD -expressing oocytes in the continuous presence of saturating glycine and glutamate concentrations (100 M each) by measuring the ratio of the peak (I p ) and steady-state (I ss ) current as an estimate for receptor desensitization. Figure 3C , left, shows typical traces recorded from wt NR1/NR2A and mutant NR1 ⌬NTD / NR2A ⌬NTD receptors, which rapidly reached peak amplitude and then strongly decayed to steady-state currents in the presence of agonists. For wt NR1/NR2A channels, the extent of desensitization expressed as a percentage of the peak current was 83 Ϯ 2.4% (n ϭ 13), whereas mutant receptors showed a significantly decreased extent of desensitization (51 Ϯ 1.3%; n ϭ 13) (Fig. 3D) . Analysis of wt NR1/NR2B and mutant NR1 ⌬NTD /NR2B ⌬NTD receptors revealed no differences in the desensitization ratios with values of 54 Ϯ 1.2 and 54 Ϯ 5.5% (n ϭ 13), respectively (Fig. 3, C, right traces, and D) . Overall, these data clearly show that the NTDs of the NR1 and NR2 subunits are not required for NMDA receptor assembly and membrane insertion but may play a role in determining receptor-kinetics.
The NR1-NTD Was Required for High-Affinity Zn
2؉
Inhibition of NR1/NR2A Receptors. The NTD of the NR2A subunit is known to harbor crucial determinants of the voltage-independent, high-affinity inhibition by Zn 2ϩ (Choi and Lipton, 1999; Fayyazuddin et al., 2000; (Table 2 ). Both single and double deletions of the NTDs of the NR1 and/or NR2B subunits markedly increased to a similar extent the concentration of Zn 2ϩ required to half-maximally inhibit NR1/NR2B receptors ( Fig. 4B ; Table 2 ). We furthermore examined the role of the NTDs for inhibition by the synthetic neuroprotective compound ifenprodil, which has been reported to allosterically inhibit NMDA receptors via the NTD of the NR2B subunit (Perin-Dureau et al., 2002) . At wt NR1/NR2B receptors, ifenprodil displayed an IC 50 value of 0.89 Ϯ 0.08 M (Fig. 4C) . Again, single as well as double deletions of the NTDs of NR1 and NR2B subunits caused a Ͼ100-fold reduction in inhibitory potency (Fig. 4C, Table 2 ). Overall, our data emphasize the importance of both the NR1-and NR2-NTDs for high-affinity allosteric Zn 2ϩ and ifenprodil inhibition of NR1/NR2A and NR1/NR2B receptors.
Residual Zn 2؉ and Ifenprodil Inhibition of NTD-Deleted Receptors Was Mediated by Both Voltage-Dependent and -Independent Low-Affinity Components. To reveal whether the residual low-affinity Zn 2ϩ -and ifenprodil inhibition seen with NTD-deleted NR1/NR2B receptors (see Table 2 ) is mediated by either a channel-blocking effect or a voltage-independent low-affinity site, we analyzed the current-voltage relationship of agonist currents recorded in the presence of Zn 2ϩ . Whereas in Mg 2ϩ -free medium, the current-voltage relation of wt NR1/NR2B receptors was linear in the presence of 10 M Zn 2ϩ (Fig. 5A) , the inhibition of NTD-deleted NR1 ⌬NTD /NR2B, NR1/NR2B ⌬NTD , and NR1 ⌬NTD /NR2B ⌬NTD receptors seen in the presence of 100 M Zn 2ϩ was found to be composed of a voltage-dependent and -independent component (Fig. 5, B-D) . The latter, detected at positive holding potentials, is likely mediated via a separate Zn 2ϩ binding site located within domains distinct from the NTDs (see Fayyazuddin et al., 2000; Rachline et al., 2005) . Similar to Zn 2ϩ inhibition, the remaining ifenprodil effect observed with the NTDdeleted receptors displayed voltage dependence at negative holding potentials (not shown). We therefore conclude that, besides a voltage-dependent channel block, NR1/NR2A and NR1/NR2B receptors harbor a common voltage-independent Zn 2ϩ -binding site outside the NTDs responsible for voltageindependent low-affinity Zn 2ϩ inhibition. Removal of NR1-and/or NR2B-NTDs Reduced Glycine Affinity. We initially observed that thrombin cleavage of EGFP-NR1 TCS /NR2B receptors reduced not only their Zn 2ϩ sensitivity but also increased the EC 50 value of glycine (0.30 Ϯ 0.04 versus 0.80 Ϯ 0.14 M). This prompted us to determine the apparent glutamate and glycine affinities of NTD-deleted NR1/NR2A and NR1/NR2B receptors. In agreement with previous studies (Laurie and Seeburg, 1994; Priestley et al., 1995) , the glycine affinities of NR1/NR2A and NR1/NR2B receptors were found to be significantly different (Fig. 6A) , with EC 50 values of 1.7 Ϯ 0.2 versus 0.39 Ϯ 0.04 M, respectively (p Ͻ 0.001; Tables 1 and 2 ). We saw significant changes in glycine EC 50 values only with NTD-deleted NR1/NR2B receptor combinations (Fig. 6B, Tables 1 and 2 ), whereas the glycine affinity of NR2A-containing receptors remained unaltered upon NTD removal (Fig. 6B, Table 1 ). No changes in glutamate affinities were obtained for either NR1/ NR2A or NR1/NR2B receptors after NTD-deletion (Tables 1  and 2 ). Hence, both the NR1-and the NR2B-NTDs are essential for high-affinity glycine binding to NR1/NR2B receptors.
To further examine whether the NR2-NTDs play a role in determining the different glycine affinities of distinct NMDA receptor subtypes, we used two chimeric constructs in which the NTD of NR2A was replaced by the corresponding NR2B-NTD (NR2A NTD2B ), and vice versa (NR2B NTD2A ), as detailed previously (Paoletti et al., 2000) . NR1/NR2A NTD2B receptors were found to have the same glycine EC 50 value as wt NR1/ NR2B receptors (Fig. 6, A and B ; 0.28 Ϯ 0.09 versus 0.39 Ϯ 0.04 M; p Ͼ 0.05, n ϭ 4), which was significantly different from the EC 50 value of the wt NR1/NR2A receptor (p Ͻ 0.01, n ϭ 5). Inversely, NR1/NR2B NTD2A receptors displayed an TABLE 2 Pharmacology of NMDA receptors assembled from wt and NTD-deleted NR1/NR2B subunits Glycine and glutamate EC 50 values were determined in the presence of 100 M glutamate or glycine, respectively. IC 50 values of Zn 2ϩ and ifenprodil were obtained by preincubating the cells with the allosteric inhibitor followed by coapplying the inhibitor with 100 M each glutamate and glycine. cRNAs were injected at a NR1/NR2 ratio of 1:2, and recordings were performed after 2 to 3 days of expression. Values represent means Ϯ S.E. Number of experiments was between 5 and 21. apparent glycine affinity indistinguishable from that of wt NR1/NR2A receptors (Fig. 6, A and B; 2.4 Ϯ 0.4 versus 1.7 Ϯ 0.3 M, p Ͼ 0.05, n ϭ 3). In contrast, no significant differences in glutamate affinities between wt NR1/NR2A and NR1/NR2B receptors and the respective chimeric receptors were observed (Fig. 6C) . Thus, the NTDs of NR2A and NR2B determine not only allosteric inhibition but also the glycine affinity of different NMDA receptor subtypes.
Discussion
In this article, we examined the contributions of the Nterminal LIVBP-homology domains of the NR1 and the NR2 subunits to NMDA receptor assembly, function, and allosteric inhibition. We showed that the NTDs are not required for subunit assembly and channel function. However, high-affinity inhibition by Zn 2ϩ or ifenprodil was abolished upon NTD deletion of either the NR1 or NR2 subunit, indicating that both NTDs are required for allosteric receptor inhibition. Furthermore, the different apparent glycine affinities of NR1/NR2A versus NR1/NR2B receptors were found to be determined by their respective NR2-NTDs.
Role of the NTDs in NMDA Receptor Modulation. Several studies have shown that the LIVBP-like domains in both ionotropic and metabotropic GluRs are capable of specifically forming dimers or higher-order oligomers via interdomain interactions (Kuusinen et al., 1999; Kunishima et al., 2000) . In non-NMDA receptors of the iGluR family, these interactions have been implicated in subunit assembly (Ayalon and Stern-Bach, 2001; Matsuda et al., 2005) . Here, we show that NTD-deleted NMDA receptor subunits form functional channels with agonist-induced currents similar to those of wt receptors; this clearly excludes an essential role of the NTDs in the assembly of NR1/NR2 receptors. This finding is consistent with the data obtained by others Hu and Zheng, 2005) , where deletion of the NR2 NTDs resulted in functional NMDA receptors. However, Meddows et al. (2001) reported that deletion of the first 380 amino acid residues of the NR1 subunit impairs subunit oligomerization. We attribute this different result to the longer deletion used by these authors than that studied here. Our data are also in agreement with studies obtained for other members of the iGluR family, which demonstrate proper assembly of natural and recombinant subunits lacking an NTD (Chen et al., 1999; Pasternack et al., 2002) .
Although interactions between the NTDs of the NMDA receptor subunits are not required for receptor assembly, both thrombin-mediated cleavage of the NR1-NTD and deletion of the NR1-or NR2-NTDs abrogated voltage-independent high-affinity Zn 2ϩ and ifenprodil inhibition. This clearly demonstrates that the NR1-NTD is required for the inhibitory effects exerted by these allosteric inhibitors, although both have shown to bind to the NR2-NTDs (overview in Herin and Aizenman, 2004) . The residual low-affinity voltage-independent and -dependent inhibition observed upon NTD deletion are probably due to additional binding sites located outside the NTDs and within the channel region, respectively (Paoletti et al., 1997 , Traynelis et al., 1998 Rachline et al., 2005) .
Model of NTD-Mediated Inhibition. Previous studies indicate that both ifenprodil and Zn 2ϩ share common binding sites and mechanisms, which result in increased NMDA receptor desensitization upon binding-induced domain closure of the LIVBP-homology region (Chen et al., 1997; Paoletti et al., 1997 Paoletti et al., , 2000 Krupp et al., 1998; Low et al., 2000; Zheng et al., 2001) . This is also consistent with our finding that removal of the NTDs of the NR1/NR2A receptor slows receptor desensitization. Based on these data, we favor a mechanism of NTD-mediated NMDA receptor inhibition that is adapted from a recent model of AMPA receptor activation (Mayer, 2006) and relies on 1) the crystallographically demonstrated heterodimeric arrangement of NR1 and NR2 subunits (Furukawa et al., 2005) and 2) iGluR desensitization resulting from a disruption of LBD interdomain-interactions (Armstrong et al., 2006) . Accordingly, binding of an allosteric inhibitor to the NR2-NTD is proposed to induce closure of the LIVBP-homology domain and to thereby produce a conformational strain, which weakens interdomain interactions be- tween NR1-and NR2-LBDs (Fig. 7) . This facilitates receptor desensitization upon agonist binding. An important feature of our model is that only binding of an allosteric modulator to an NR2-NTD stabilized by an adjacent NR1-NTD would be able to sufficiently weaken the interactions between NR1 and NR2 LBDs (Fig. 7) (Armstrong et al., 2006) . This implies that the NR1 and NR2 LIVBP homology domains form a heterodimer, an idea that is entirely consistent with both the heterodimeric arrangement of NR1 and NR2 subunits (Furukawa et al., 2005) and our data showing that both the NR1 and NR2 NTDs equally contribute to high-affinity Zn 2ϩ and ifenprodil inhibition. Our model assigning an important role to the NTD heterodimer (Fig. 7) is also consistent with the observation that the glycine affinity of NMDA receptors containing chimeric NR2 subunits is determined by their respective NR2-NTDs.
Contribution of NTDs in Determining Agonist Affinity. The pharmacological profile of NMDA receptors is known to crucially depend on the NR2 subunit isoform incorporated (Laurie and Seeburg, 1994; overview in Cull-Candy et al., 2001) . For example, NR1/NR2B receptors have a 10-fold higher glycine affinity than NR1/NR2A receptors (Laurie and Seeburg, 1994; Priestley et al., 1995 ; current study), although both receptors share the same glycine-binding NR1 subunit. Here, we showed that upon coexpression with NR1, a chimeric NR2A subunit containing the NTD of NR2B generates receptors displaying the high glycine affinity characteristic of wt NR1/NR2B receptors. Vice versa, the EC 50 value of glycine at NR1/NR2B
NTD2A receptors was similar to that determined for wt NR1/NR2A receptors. These results are consistent with the observation that mutations within NR2-NTDs can affect apparent glycine affinity (Choi et al., 2001) . All these findings can be explained by allosteric interactions between the NTDs of the NMDA receptor subunits, which determine both the affinity of glycine binding to the Table 2 ). Note that current-voltage curves for wt NR1/NR2B (A) receptors in the presence of 10 M Zn 2ϩ exhibit only a high-affinity voltage-independent inhibition, whereas NR1 NR1 subunit and the efficacy of allosteric inhibitors at the NR2 subunits.
Implications for the Pathology and Therapy of t-PATriggered Neurotoxicity. Excessive stimulation of NMDA receptors is known to cause neuronal cell death by apoptosis or necrosis as a result of enhanced Ca 2ϩ influx (overview in Cull-Candy et al., 2001) . NMDA receptors are tonically inhibited by Zn 2ϩ , a mechanism that has been shown to protect neurons against NMDA receptor-mediated glutamate toxicity in vitro (Chen et al., 1997) . Here, we demonstrate that deletion of the NR1-NTD by thrombin abolishes high-affinity Zn 2ϩ inhibition of NR1/NR2A receptors. Tissue-type plasminogen activator (t-PA), an endogenous serine protease, has been found to potentiate NMDA receptor currents through cleavage of the NR1-NTD, which has been implicated in pathophysiological aspects of glutamatergic neurotransmission (Nicole et al., 2001; Ferná ndez-Monreal et al., 2004) . After focal cerebral ischemia, t-PA triggers the neurotoxic cascade mediated by elevated concentrations of glutamate (Tsirka et al., 1995) . Blockade of this serine protease in cortical neuron cultures has been reported to reduce NMDA-induced excitotoxic cell death (Nicole et al., 2001 ). Because we found a loss in Zn 2ϩ inhibition of both NR1/NR2A and NR1/NR2B receptors upon thrombin cleavage and deletion of the NR1-NTD, our results might provide an explanation for the enhanced NMDA receptor activity seen in the presence of t-PA. Accordingly, relief of NMDA receptors from tonic Zn 2ϩ inhibition (Rachline et al., 2005) by t-PA-mediated cleavage of the NR1-NTD would result in enhanced Ca 2ϩ influx and thereby cause neuronal cell death. This mechanism should be particularly effective at synaptically localized NR1/NR2A receptors, as a result of their high-affinity Zn 2ϩ -binding site. 
